The novel approach of the medication represents a significant breakthrough in the management of the condition. Different to existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide625643.newbigblog.com/48994209/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment